Data from Study of Champions Oncology TumorGrafts to be Presented at European Society for Medical Oncology (ESMO) 2014 Congress
Hackensack, NJ – September 24, 2014 – Champions Oncology (CSBR) a company engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced that data from a study of Champions’ TumorGrafts® will be presented on Monday, Sept. 29, at the European Society for Medical Oncology (ESMO) 2014 Congress.
Title : Patient-derived xenografts accurately capture clinical responses to treatment
Session : Trials and tribulations in oncology : Future approaches
Abstract : 1573PD
Time : 1 p.m. CEST
Location : Pamplona (Hall 4)